CEP regimen (CCNU, etoposide, prednimustine) for relapsed/refractory Hodgkin's disease.
Zinzani PL, Barbieri E, Bendandi M, Perini F, Gherlinzoni F, Neri S, Ammendolia I, Salvucci M, Babini L, Fiacchini M, et al.
Zinzani PL, et al. Among authors: salvucci m.
Tumori. 1994 Dec 31;80(6):438-42. doi: 10.1177/030089169408000606.
Tumori. 1994.
PMID: 7900233
Clinical Trial.